Two Sigma Advisers’s IGM Biosciences IGMS Stock Holding History

Two Sigma Advisers’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-82,700	Closed	-$92.6K	–	2487
2025 Q2	$92.6K	Sell	82,700 -7,800	-9%	-$9.53K	﹤0.01%	2214
2025 Q1	$104K	Buy	+90,500	New	+$168K	﹤0.01%	2239
2022 Q1	–	Sell	-22,600	Closed	-$663K	–	2806
2021 Q4	$663K	Buy	+22,600	New	+$1.12M	﹤0.01%	1770

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Two Sigma Advisers's IGMS Position: Q3 2025 in Review

Two Sigma Advisers sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 82,700 shares — an estimated $92.6K sold.

Two Sigma Advisers first reported a position in IGMS in Q4 2021 and held it in 3 quarters. The position peaked at $663K in Q4 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Two Sigma Advisers reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Two Sigma Advisers sold 82,700 IGM Biosciences shares in Q3 2025, an estimated $92.6K.
Two Sigma Advisers first reported a position in IGM Biosciences in Q4 2021 and held it in 3 quarters.
Two Sigma Advisers's IGM Biosciences position peaked at $663K in Q4 2021.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.